705
Participants
Start Date
April 29, 2013
Primary Completion Date
December 2, 2019
Study Completion Date
June 24, 2022
Ixazomib
IXAZOMIB capsules.
Placebo
IXAZOMIB matching-placebo capsules.
Dexamethasone
Dexamethasone tablets.
Lenalidomide
Lenalidomide capsules.
Birmingham
Chandler
Tucson
Little Rock
Anaheim
Corona
Fountain Valley
Fullerton
Irvine
La Jolla
Mission Hills
Oakland
Riverside
San Diego
San Jose
San Leandro
Santa Clara
South San Francisco
Vallejo
Denver
Fort Collins
Hartford
Plainville
Fort Myers
Jacksonville
Miami
Miami Beach
West Palm Beach
Atlanta
Marietta
Honolulu
Iowa City
Sioux City
Louisville
Shreveport
Baltimore
Towson
Burlington
Worcester
Ann Arbor
Lansing
Southfield
Duluth
Minneapolis
Rochester
Bridgeton
Kansas City
Little Silver
Albuquerque
Farmington
Las Cruces
Buffalo
Lake Success
New York
Poughkeepsie
Cincinnati
Cleveland
Tulsa
Eugene
Portland
Hershey
Pittsburgh
Scranton
Charleston
Cookeville
Nashville
Austin
Galveston
San Antonio
Temple
Tyler
Christiansburg
Richmond
Everett
Seattle
Spokane
Vancouver
Yakima
Brussels
Yvoir
Ghent
Leuven
Roeselare
Bruges
Liège
Calgary
Edmonton
Surrey
Victoria
Saint John
Halifax
Hamilton
London
Toronto
Fleurimont
Lévis
Montreal
Nice
Strasbourg
Brest
Saint-Brieuc
Limoges
Castelnau-le-Lez
La Tronche
Nantes
Angers
Reims
Vandœuvre-lès-Nancy
Vannes
Lille
Lens
Saint-Priest-en-Jarez
Montivilliers
Poitiers
Amiens
Bayonne
Bordeaux
Caen
Chalon-sur-Saône
Créteil
Dunkirk
La Roche-sur-Yon
Le Chesnay
Le Mans
Lille
Montpellier
Mulhouse
Paris
Périgueux
Pierre-Bénite
Pontoise
Rouen
Toulouse
Tours
Auckland
Wellington
Christchurch
Dunedin
Hamilton
Ryazan
Goyang
Seongnam-si
Daegu
Daejeon
Incheon
Jeongnam
Seoul
Lead Sponsor
Millennium Pharmaceuticals, Inc.
INDUSTRY